Jaguar Gene Therapy is advancing progress in gene therapy for individuals afflicted by serious genetic conditions. Headed by the former AveXis leadership group and supported by Deerfield Management, a healthcare-focused investment company, Jaguar introduces efficient R&D, production, and clinical activities to expedite the advancement and potential authorization of treatments for severe genetic diseases. The organization’s current portfolio utilizes the established and well-defined AAV9 vector to ta